Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OXFD

Oxford Immunotec Global (OXFD) Stock Price, News & Analysis

Oxford Immunotec Global logo

About Oxford Immunotec Global Stock (NASDAQ:OXFD)

Advanced Chart

Key Stats

Today's Range
$21.99
$21.99
50-Day Range
$21.88
$21.99
52-Week Range
$8.37
$23.11
Volume
N/A
Average Volume
1.10 million shs
Market Capitalization
$570.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OXFD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Immunotec Global and its competitors with MarketBeat's FREE daily newsletter.

OXFD Stock News Headlines

A Game-Changing Vaccine
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
Nigeria rolls out new Oxford R21 malaria vaccine
See More Headlines

OXFD Stock Analysis - Frequently Asked Questions

Oxford Immunotec Global PLC (NASDAQ:OXFD) issued its quarterly earnings results on Tuesday, November, 3rd. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.01). The business had revenue of $19.44 million for the quarter, compared to the consensus estimate of $18.58 million. Oxford Immunotec Global had a negative trailing twelve-month return on equity of 8.39% and a negative net margin of 30.51%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Immunotec Global investors own include Intel (INTC), Gilead Sciences (GILD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Dynavax Technologies (DVAX), Enterprise Products Partners (EPD) and Gold Resource (GORO).

Company Calendar

Last Earnings
11/03/2020
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:OXFD
CIK
1586049
Fax
N/A
Employees
273
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.81 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$73.71 million
Cash Flow
$0.02 per share
Price / Cash Flow
1,408.78
Book Value
$8.08 per share
Price / Book
2.72

Miscellaneous

Free Float
N/A
Market Cap
$570.90 million
Optionable
Not Optionable
Beta
1.42
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:OXFD) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners